Arkolith/Insider Trading/JANX/Form 4

Doyle Janeen Noel

Chief Corp. & Bus. Dev. OfcrJanux Therapeutics, Inc. (JANX) · full profile →Form 4 · filed Jun 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$57K
Net Open-Market Flow
-$57K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2026Sell(S)4K$14.03$57K76K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002069239-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML